FDA Approved: ARMODAFINIL — Original Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved Mylan's original ANDA for armodafinil, a generic wakefulness-promoting drug, for the treatment of excessive daytime sleepiness in narcolepsy, obstr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Excessive Daytime Sleepiness Associated with Obstructive Sleep Apnea Hypopnea Syndrome
• Narcolepsy
• Shift Work Sleep Disorder

Drugs mentioned

• Armodafinil (armodafinil)

Snippet

ORIG AP for ARMODAFINIL (ARMODAFINIL)